Find uplifting stories about heroes, innovations, and solutions
12005 results for "weight management"
Postmenopausal women combining hormone therapy with a popular weight loss drug lost 35% more weight than those taking the medication alone. The finding could transform how millions of women manage weight gain after menopause.
A new weight-loss pill from AstraZeneca helped trial participants lose nearly 12% of their body weight in just nine months, offering fresh hope in the race to make weight management easier. The tablet could soon give doctors and patients another powerful tool in fighting obesity.
A breakthrough study shows the diabetes drug semaglutide helps older adults lose significant weight safely while improving heart health. Nearly half of participants over 65 achieved at least 15% weight loss in just over a year.
A new experimental obesity treatment targeting three hormones has shown significant weight loss in early testing. The "triple-G" drug from Kailera offers fresh hope in the rapidly expanding field of weight management medicine.
A new diabetes treatment from Eli Lilly helped patients lose 15% of their body weight while improving blood sugar control, potentially becoming the most effective weight loss diabetes drug yet. The results offer hope for millions who struggle to shed pounds while managing their condition.
A new daily pill helped people with type 2 diabetes lose up to 8% of their body weight in a year-long study, outperforming current oral alternatives. The convenient treatment could make weight management more accessible for millions.
Millions of Americans now have a new option for weight management that doesn't require needles or strict meal planning. The FDA just approved Foundayo, a once-daily pill that can be taken anytime with or without food.
Pfizer's experimental obesity drug could change weight loss treatment from 52 injections per year to just 12. The once-monthly therapy showed promising results while making long-term treatment far more convenient for patients.
New real-world data shows many patients who stop taking popular weight loss drugs like Wegovy and Zepbound don't quickly regain the weight they lost. The findings challenge earlier concerns that the benefits disappear when treatment ends.
Cancer survivors struggling with treatment-related weight gain now have a personalized path forward. Sylvester Cancer Center just launched RENEW, a 12-week program designed specifically for safe weight loss after cancer treatment.
Scientists have found two promising methods to help people maintain their weight loss after stopping diets or GLP-1 medications like Wegovy. New research shows a daily pill and a probiotic supplement can both help prevent the frustrating cycle of weight regain.
A pill-based weight loss medication achieved up to 12% body weight reduction in clinical trials, offering a more accessible alternative to injectable drugs like Ozempic. The oral drug could transform obesity treatment by eliminating needles, refrigeration, and high manufacturing costs.
A promising triple-action medication could help people lose weight without sacrificing muscle. Retatrutide shows potential for safer weight loss with fewer side effects than earlier medications.
People using GLP-1 weight loss medications may not need weekly injections forever. A new study shows many patients maintain their weight loss while spacing out doses to every two or even six weeks.
Scientists are testing a breakthrough obesity treatment that helps people lose up to a third of their body weight without sacrificing muscle mass. The triple-action drug retatrutide could solve one of the biggest problems with current weight-loss medications.
%2Fhttps%3A%2F%2Ftf-cmsv2-smithsonianmag-media.s3.amazonaws.com%2Ffiler_public%2Ff8%2Ff8%2Ff8f86afc-d21d-40cc-86c9-e212d1e51222%2Fleslie_leinwand_snake_research_0181.jpg)
Scientists discovered an appetite-suppressing molecule in python blood that helped obese mice lose 9% of their body weight without the stomach problems that plague current weight-loss drugs. This breakthrough could lead to a new generation of treatments inspired by nature's most extreme fasters.
Twenty-three students pursuing careers in pest management just received scholarships worth up to $2,000 each to continue their education. The Pest Management Foundation's 2025-2026 awards support the next generation of professionals protecting public health and food safety.
People taking weight loss drugs like Wegovy are successfully maintaining their results by spacing out injections to every two weeks instead of weekly. A new study shows most patients kept the weight off and their health improvements without weekly shots.
New research shows that people who lost the most weight on GLP-1 medications like Ozempic dramatically reduced their risk of serious health problems. Those who shed at least 15% of their body weight saw sleep apnea risk drop by 69% and kidney disease risk fall by 30%.
Scientists discovered that two genes can help predict who will lose weight on popular obesity medications and who might experience side effects. The breakthrough could personalize treatment for millions seeking help with weight loss.
Showing 20 of 12005